The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy;Přínos ERG v časné diagnostice chlorochinové a hydroxychlorochinové makulopatie

Ceska a Slovenska Oftalmologie

Volumn 66, Issue 2, 2010, Pages 62-66

  Karkanova M ^a   Matuskova V ^a   Vlkova E ^a   Doskova H ^a   Uhmannova R ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Antimalarics; Drug cumulative maculopathy; ERG

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; CHLOROQUINE; HYDROXYCHLOROQUINE;

ARTICLE; CHEMICALLY INDUCED DISORDER; ELECTRORETINOGRAPHY; HUMAN; MIDDLE AGED; RETINA DISEASE; RETINA MACULA LUTEA;

ANTIMALARIALS; ANTIRHEUMATIC AGENTS; CHLOROQUINE; ELECTRORETINOGRAPHY; HUMANS; HYDROXYCHLOROQUINE; MACULA LUTEA; MIDDLE AGED; RETINAL DISEASES;

EID: 77955953331     PISSN: 12119059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Araiza-Casilas, R., Cardenas, F., Morales, Y.: Factors associated with chloroguine-induced retinopathy in rheumatic diseases. Lupus. 2004, 13, s. 119-124
2. Bui Quoc, E., Ingster-Moati, I., Rigolet, MH.: Ophthalmologic prevention of chloroguine and hydroxychloroguine induced retinopathy. Annales de Dermatologie et de Venerologie. 2005, 132, 4, s. 329-337
3. Cambiaggi, A.: Unusual ocular lesions in case of systemic lupus erythematodes. AMA Arch. Ophthalmol. 1957, 57, s. 451-453
4. Easterbrook, M., Bernstein, H.: Ophthalmological monitoring of patients taking antimalarials: preferred practice pattern. The Journal of Rheumatology. 1997, 24, 7, s. 1390-1392
5. Easterbrook, M.: An ophthalmological view on the efficacy and safety of chloroguine versus hydroxychloroquine. J. Rheumatol. 1999, 26, s. 1866-1868
6. Fardet, L., Revuz, J.: Synthetic antimalarials. Annales de Dermatologie et de Venereologie. 2005, 132, 8-9, s. 665-674
7. Grierson, DJ.: Hydroxychloroguine and visual screening in a rheumatology outpatient clinic. Annals of Rheumatic Diseases. 1997, 56, 3, s. 188-191
8. Hobbs, HE., Sorsby, A., Freedman, A.: Retinopathy following chloroguine therapy. Lancet. 1959, 2, s. 478
9. Ingster-Moati, I., Bui Quoc, E., Crochet, M.: Severe chloroquine and hydroxychloroquine induced retinopathy. Journal Francais d Opthalmologie. 2006, 29, 6, s. 642-650
10. Ingster-Moati, I., Crochet, M., Albuisson, E.: Electroretinogram b wave varies with the posology of the antimalarial treatment. Journal Francais d Opthalmologie. 2004, 27, 12, s. 1007-1012
11. Karkanová, M., Polanská, V., Vícha, I. et al.: Přínos ERG při screeningu chlorochinové a hydroxychlorochinové makulopatie, 55, In: Sborník abstrakt XV. výročního sjezdu České oftalmologické společnosti s mezinárodní účastí v Brně. Ed. Nucleus HK, 2007, s. 187, ISBN 978-80-87086-01-08.
12. Lai, T.Y., Ngai, J.W., Chan, W.M.: Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroguine therapy. 2006, 112, 3, s. 177-187
13. Maturi, R.K., Yu, M., Weleber, R.G.: Multifocal electroretinographic evaluation of long-term hydroxychloroguine users. Archives of Ophthalmology. 2004, 122, 7, s. 973-981
14. Mavrikakis, I. et al.: The incidence of irreversible retinal toxicity in patients treated with hydroxychloroguine: a reappraisal. Ophthalmology. 2003, 110, 7, s. 1321-1326
15. Neubauer, AS., Stiefelmeyer, S., Berninger, T.: The multifocal pattern electroretinogram in chloroguine retinopathy. Ophthalmic Research. 2004, 36, 2, s. 106-113 (Pubitemid 38437658)
16. Rigaudiere, F., ingster-Moati, I., Hache, J.C.: Up-dated ophthalmological screening and follow-up management for long-term antimalarial treatment. Source Journal Francais d Ophthalmologie. 2004, 27, 2, s. 191-199
17. Scherbel, A.L., Mackenzie, A.H., Nousek, J.E.: Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy. The New England Journal of Medicine. 1965, 12, 8, s. 360-366
18. Svěrák, J., Erbenová, Z., Peregrin, J.: ERG and EOG potentials after 6 years rescoring treatment. Sborník vědeckých prací Lékařské fakulty UK v Hradci Králové. 1971, 14, 2, s. 209-213
19. Svěrák, J., Peregrin, J., Salavec, M.: Electrophysiological methods of examination during prolonged administration of synthetic antimalarial drugs. Sborník vědeckých prací Lékařské fakulty UK v Hradci Králové. 1976, 19, 3-4, s. 427-434
20. Svěrák, J., Salavec, M., Peregrin, J.: Vliv antimalarik na činnost sítnice. Čs. Oftal. 1965, 21, 5, s. 370-378
21. Tokumaru, G.K.: New considerations in monitoring for hydroxychloroguine retinopathy. Clinical Eye and Vision Care. 1996, 8, s. 99-104
22. Tzekov, R.: Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Documenta Ophthalmologica. 2005,110, s. 111-120
23. Wei, L.C., Chen, S.N., Ho, C.L.: Progression of hydroxychloroguine retinopathy after discontinuation of therapy. Chang Gung Medical Journal. 2001, 24, 5, s. 329-334